This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jetten, A. M. Articles by Shudo, K. Search for Related Content PubMed PubMed Citation Articles by Jetten, A. M. Articles by Shudo, K.

New Benzoic Acid Derivatives with Retinoid Activity: Lack of Direct Correlation between Biological Activity and Binding to Cellular Retinoic Acid Binding Protein

Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [A. M. J., K. A., M. A. D., J. I. R.]; Faculty of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan [H. K., K. S.]; and Department of Tumor Biology, The University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030 [R. L.]

In this paper the biological activity of several newly synthesized benzoic acid derivatives of the Am- and Ch- series, which are structurally different from retinoic acid and arotinoids, was examined. These compounds inhibit squamous cell differentiation of rabbit tracheal epithelial cells in vitro as indicated by the inhibition of transglutaminase Type I and cholesterol 3-sulfate levels. In contrast to the inhibition of differentiation in rabbit tracheal cells, these compounds induce differentiation of mouse embryonal carcinoma F9 and human promyelocytic leukemia HL60 cells. The Am- and Ch- series of compounds also affect several parameters of cell proliferation. These agents are very potent inhibitors of growth of melanoma S91 cells and inhibit the induction of ornithine decarboxylase activity by phorbol 12-myristate 13-acetate in 3T6 fibroblasts. These results show that the Am- and Ch- derivatives elicit in several cell systems the same cellular responses as retinoic acid. We propose, therefore, that they exhibit mechanism(s) of action similar to those of retinoids. Comparison of the biological response with the binding capacity to the cellular retinoic acid-binding protein shows a lack of a direct correlation.

¹ To whom requests for reprints should be addressed.

Received 11/17/86. Revised 2/27/87. Accepted 3/25/87.

This article has been cited by other articles:

				S. Orita, M. Hirose, S. Takahashi, K. Imaida, N. Ito, K. Shudo, H. Ohigashi, A. Murakami, and T. Shirai Modifying Effects of 1'-Acetoxychavicol Acetate (ACA) and the Novel Synthetic Retinoids Re-80, Am-580 and Am-55P in a Two-Stage Carcinogenesis Model in Female Rats Toxicol Pathol, February 1, 2004; 32(2): 250 - 257. [Abstract] [PDF]

				J van der Wees, J. Schilthuis, C. Koster, H Diesveld-Schipper, G. Folkers, P. van der Saag, M. Dawson, K Shudo, B van der Burg, and A. Durston Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the developing hindbrain Development, January 2, 1998; 125(3): 545 - 556. [Abstract] [PDF]

				J. M. Richman The Role of Retinoids in Normal and Abnormal Embryonic Craniofacial Morphogenesis Critical Reviews in Oral Biology & Medicine, January 1, 1992; 4(1): 93 - 109. [Abstract] [Full Text] [PDF]